Stockscreener 앱 받기
42.85
0.90%
0.3826
전일 마감가:
$42.47
열려 있는:
$42.15
하루 거래량:
25,731
Relative Volume:
1.15
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-2.80%
1개월 성능:
-9.00%
6개월 성능:
+24.17%
1년 성능:
+136.74%
1일 변동 폭
$42.09
$42.96
1주일 범위
$40.08
$43.59
52주 변동 폭
$17.67
$48.18
Virtus Biotech Clinical Trials Etf Stock (BBC) Company Profile
Compare BBC vs VTI, SPY, IVV, VB, QQQ
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BBC
Virtus Biotech Clinical Trials Etf
|
42.92 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
363.13 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
739.19 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
742.57 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
283.95 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
710.38 | 124.43B | 0 | 0 | 0 | 0.00 |
Virtus Biotech Clinical Trials Etf 주식(BBC)의 최신 뉴스
Kodiak Sciences Inc stock (US50012K1051): earnings loss widens as biotech pushes retina pipeline - AD HOC NEWS
Inhibrx Inc stock (US45720L1070): Biotech firm in Virtus ETF holdings - AD HOC NEWS
Anatomy of an AI Trade: How I Use AI to Make Money in Stocks - Money Talks News
(BBC) Risk Channels and Responsive Allocation - Stock Traders Daily
(BBC) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Virtus LifeSci Biotech Clinical Trials ETF declares annual distribution of $0.6554 - MSN
Biotech ETF (BBC) touches fresh 52-week high - MSN
Liquidity Mapping Around (BBC) Price Events - Stock Traders Daily
Biotech ETF (BBC) Touches Fresh 52-Week High - TradingView
Why (BBC) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Virtus Biotech Clinical Trials Etf Share Price (BBC.US) - London South East
Understanding Momentum Shifts in (BBC) - Stock Traders Daily
Biotech Stocks and Longevity Investing: Trends To Track - Newsweek
Biotech Stock Up 372% Gets Sold as New Pick Rises 40% in 2026 - AOL.com
Biotech stocks and longevity investing: Trends to track - Laclede County Record
Biotech Stocks & Longevity Investing: Trends to Track - The Motley Fool
Avoiding Lag: Real-Time Signals in (BBC) Movement - Stock Traders Daily
Discipline and Rules-Based Execution in BBC Response - Stock Traders Daily
Stock List: Research Stocks from Around the World - GuruFocus
BBC Technical Analysis & Stock Price Forecast - Intellectia AI
BBC Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Behavioral Patterns of BBC and Institutional Flows - Stock Traders Daily
Wall Street Thinks These 4 Biotech Stocks Will Double–At Least–This Year - AOL.com
Apogee Stock Jumps 87% in One Year as This Biotech Fund Lifts Stake to $93 Million - AOL.com
(BBC) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
How (BBC) Movements Inform Risk Allocation Models - Stock Traders Daily
Trading Systems Reacting to (BBC) Volatility - Stock Traders Daily
Why ImmunityBio Stock Is Skyrocketing Again Today - AOL.com
How Virtus Lifesci Biotech Clinical Trials Etf (BBC) Affects Rotational Strategy Timing - Stock Traders Daily
What's Going On With Alumis Stock Thursday? - Sahm
Daily News - FinancialContent
Los Angeles Daily NewsVirtus LifeSci Biotech Clinical Trials ETF (NYSE:BBC) Stock Quote - FinancialContent
Can ETF Winners of Q4 of 2025 Rally in Q1 of 2026? - TradingView — Track All Markets
Biotech ETF (BBC) Hits New 52-Week High - MSN
(BBC) and the Role of Price-Sensitive Allocations - Stock Traders Daily
ETFs Investing in enGene Holdings Inc. Stocks - TradingView — Track All Markets
Healthcare ETFs Trounce Tech, Grab Billions As Big Money Flees Bubble Fears - Sahm
The Zacks Analyst Blog Highlights LLY, EPHE, BBC, HELX, XHS and SURI - Yahoo Finance
Best-Performing ETFs of Last Week: Healthcare Rules - sharewise.com
Is Virtus LifeSci Biotech Clinical Trials stock positioned for digital growth eraWeekly Trade Report & Low Risk Investment Opportunities - newser.com
Intellia Therapeutics: A Worst-Case Risk Becomes A Tragic Reality (Downgrade) - Seeking Alpha
Best-Performing ETFs of Last Week - Zacks Investment Research
Virtus Biotech Clinical Trials Etf (BBC) 재무 분석
Virtus Biotech Clinical Trials Etf (BBC)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.26%
자본화:
|
볼륨(24시간):